BELFA vs BELFB

BELFA's Advanced Deterministic Scorecard reveals weak financial health with a Piotroski F-Score of 3/9, indicating significant concerns in profitability, leverage, and operating efficiency. Despite this, the company exhibits strong recent growth, with 44.80% YoY revenue growth and 172.90% earnings growth, supported by consistent earnings beats and high profitability margins. Valuation appears stretched at a P/E of 37.63 versus a Graham Number of $60.47, though sector context (avg P/E 93.05) suggests relative reasonableness. The lack of Altman Z-Score and analyst coverage, combined with weak insider sentiment and deteriorating technical trend, offsets strong fundamentals and growth momentum.

BELFB exhibits weak fundamental health with a Piotroski F-Score of 3/9, indicating significant financial fragility. Despite strong recent earnings and revenue growth—YoY earnings up 172.9% and revenue up 44.8%—the stock trades at a premium valuation (P/E 40.52 vs. sector avg 93.05) with limited margin of safety relative to the Graham Number of $60.72. Robust profitability metrics like 17.09% operating margin and 16.91% ROE are offset by bearish insider activity and deteriorating technical trends (10/100). While analyst consensus is strong_buy, conflicting signals across valuation, health, and insider behavior warrant caution.